ClearPoint Neuro, Inc.
NASDAQ:CLPTMedical - Devices
+$0.89 today
- Market cap
- $247.14M
- Beta
- 1.31
- P/E (TTM)
- -18.0
- EPS (TTM)
- -$0.98
Volume 0.64M
Average 0.67M
CLPT Other Non-current Assets
Long-term assets not reported separately.
ClearPoint Neuro, Inc.NASDAQ: CLPT
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets rises 1012.2% from a year ago
Other non-current assets stood at $1.65M at the end of Q1 FY2026, up 1012.2% from a year earlier and down 3.3% from the prior quarter. Over 3 fiscal years it compounded at +43.1% a year.
Context
- Other non-current assets amounted to 1.8% of total assets at the end of Q1 FY2026, up 1.3 pp from a year earlier.
- Other non-current assets increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current assets keeps rising in the next quarterly balance sheet after a +1012.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 1.7M USD
- Year-over-year change
- +578.1%
- 4-year CAGR
- +27.5%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.7M | +578.1% |
| FY2024 | 2024-12-31 | 251K | -49.3% |
| FY2023 | 2023-12-31 | 495K | -14.8% |
| FY2022 | 2022-12-31 | 581K | -9.8% |
| FY2021 | 2021-12-31 | 644K | — |
Other Non-current Assets vs competitors
How CLPT compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +1012.2% is the highest of 10, against a peer median of +2.9%.
- Other non-current assets amounts to 1.8% of total assets for CLPT, versus a peer median of 2.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $56.57M USD | +54.3% | +191.2% | 15.6% | |
| Mar 2026 | $35.48M USD | +277.5% | — | 4.0% | |
| Apr 2026 | $35.1M USD | -5.9% | -5.5% | 3.2% | |
| Mar 2026 | $32.9M USD | +29.5% | +21.4% | 3.1% | |
| Mar 2026 | $13.91M USD | +70.2% | +30.9% | 2.6% | |
| Mar 2026 | $4.71M USD | +2.9% | +31.4% | 1.0% | |
| Mar 2026 | $3.39M USD | -86.3% | +0.5% | 0.5% | |
| Mar 2026 | CA$2.51M CAD | -36.0% | -19.2% | 0.2% | |
| Mar 2026 | $1.65M USD | +1012.2% | +43.1% | 1.8% | |
| Mar 2026 | $217K USD | -28.1% | -47.3% | 0.1% | |
| Peer median (excluding CLPT) | — | +2.9% | +10.9% | 2.6% | |
Competitors are the stored peer set for CLPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 54.11M | 27.62M | 23.14M | 20.1M | 45.92M |
| Short-term Investments | 0 | 9.87M | 0 | 0 | 0 |
| Net Receivables | 2.34M | 2.67M | 3.94M | 4.71M | 7.26M |
| Inventory | 4.94M | 9.3M | 7.91M | 6.86M | 8.36M |
| Other Current Assets | 0 | 1.72M | 0 | 1.68M | 2.06M |
| Total Current Assets | 61.89M | 51.18M | 36.17M | 33.36M | 63.6M |
| Property, Plant & Equipment (Net) | 2.78M | 2.7M | 4.95M | 5.09M | 11.05M |
| Goodwill | 0 | 0 | 0 | 0 | 7.47M |
| Intangible Assets | 265K | 1.03M | 1.04M | 484K | 13.92M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 644K | 581K | 495K | 251K | 1.7M |
| Total Non-current Assets | 3.69M | 4.31M | 6.49M | 5.83M | 34.15M |
| Total Assets | 65.58M | 55.49M | 42.66M | 39.19M | 97.75M |
| Account Payables | 427K | 272K | 393K | 1.34M | 1.26M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 678K | 1.07M | 2.61M | 2.12M | 1.67M |
| Other Current Liabilities | 2.6M | 2.82M | 2.95M | 4.89M | 4.36M |
| Total Current Liabilities | 4.75M | 6.79M | 7.43M | 10.35M | 10.77M |
| Long-term Debt | 9.84M | 9.89M | 9.95M | 0 | 49.08M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 354K |
| Deferred Revenue (Non-current) | 264K | 390K | 541K | 436K | 581K |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 489K |
| Total Non-current Liabilities | 12.04M | 11.82M | 14.06M | 3.45M | 58.96M |
| Total Liabilities | 16.79M | 18.6M | 21.49M | 13.8M | 69.73M |
| Common Stock | 237K | 246K | 247K | 276K | 294K |
| Retained Earnings | (133.93M) | (150.37M) | (172.46M) | (191.37M) | (216.91M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 5.64M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 48.79M | 36.89M | 21.17M | 25.39M | 28.02M |
| Total Debt | 12.28M | 11.99M | 13.94M | 3.57M | 58.23M |
| Net Debt | (41.83M) | (15.63M) | (9.2M) | (16.54M) | 12.31M |
ClearPoint Neuro, Inc.
NASDAQ:CLPT
Intrinsic Alpha fair value
Locked
Current Price
$7.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.